Aleš Jerin1, Osama F Mosa2, Jurij M Kališnik3, Janez Žibert4, Milan Skitek1. 1. University Medical Centre Ljubljana, Institute of Clinical Chemistry and Biochemistry, Slovenia. 2. Umm Al Qura University, Health Science College at Lieth, Department of Public Health, KSA. 3. University Medical Centre Ljubljana, Department of Cardiac Surgery, Slovenia. 4. University of Ljubljana, Faculty of Health Sciences, Slovenia.
Abstract
BACKGROUND: Early diagnosis of acute kidney injury (AKI) after cardiac surgery is based on serum creatinine which is neither a specific nor a sensitive biomarker. In our study, we investigated the role of serum Klotho in early prediction of AKI after cardiac surgery using cardiopulmonary bypass (CPB). METHODS: The included patients were classified into three groups according to AKI stages using KDIGO criteria. The measurements of creatinine and Klotho levels in serum were performed before surgery, at the end of CPB, 2 hours after the end of CPB, 24 hours and 48 hours postoperatively. RESULTS: Seventy-eight patients were included in the study. A significant increase of creatinine levels (p<0.001) was measured on the first day after the surgery in both AKI groups compared to the non-AKI group. However, a significant difference between AKI-2 and AKI-1 groups (p=0.006) was not measured until the second day after the operation. Using decision trees for classification of patients with a higher or lower risk of AKI we found out that Klotho discriminated between the patients at low risk of developing more severe kidney injury in the first hours after surgery and the patients at high risk better than creatinine. Adding also the early measurements of creatinine in the decision tree model further improved the prediction of AKI. CONCLUSIONS: Serum Klotho may be useful to discriminate between the patients at lower and the patients at higher risk of developing severe kidney injury after cardiac surgery using CPB already in the first hours after surgery. 2020 Aleš Jerin, Osama F. Mosa, Jurij M. Kališnik, Janez Žibert, Milan Skitek, published by CEON/CEES.
BACKGROUND: Early diagnosis of acute kidney injury (AKI) after cardiac surgery is based on serum creatinine which is neither a specific nor a sensitive biomarker. In our study, we investigated the role of serum Klotho in early prediction of AKI after cardiac surgery using cardiopulmonary bypass (CPB). METHODS: The included patients were classified into three groups according to AKI stages using KDIGO criteria. The measurements of creatinine and Klotho levels in serum were performed before surgery, at the end of CPB, 2 hours after the end of CPB, 24 hours and 48 hours postoperatively. RESULTS: Seventy-eight patients were included in the study. A significant increase of creatinine levels (p<0.001) was measured on the first day after the surgery in both AKI groups compared to the non-AKI group. However, a significant difference between AKI-2 and AKI-1 groups (p=0.006) was not measured until the second day after the operation. Using decision trees for classification of patients with a higher or lower risk of AKI we found out that Klotho discriminated between the patients at low risk of developing more severe kidney injury in the first hours after surgery and the patients at high risk better than creatinine. Adding also the early measurements of creatinine in the decision tree model further improved the prediction of AKI. CONCLUSIONS: Serum Klotho may be useful to discriminate between the patients at lower and the patients at higher risk of developing severe kidney injury after cardiac surgery using CPB already in the first hours after surgery. 2020 Aleš Jerin, Osama F. Mosa, Jurij M. Kališnik, Janez Žibert, Milan Skitek, published by CEON/CEES.
Authors: Ci-Di Chen; Sonia Podvin; Earl Gillespie; Susan E Leeman; Carmela R Abraham Journal: Proc Natl Acad Sci U S A Date: 2007-12-03 Impact factor: 11.205
Authors: Min Young Seo; Jihyun Yang; Jun Yong Lee; Kitae Kim; Sun Chul Kim; Hyojeong Chang; Nam Hee Won; Myung-Gyu Kim; Sang-Kyung Jo; Wonyong Cho; Hyoung Kyu Kim Journal: Korean J Intern Med Date: 2015-06-29 Impact factor: 2.884